132 related articles for article (PubMed ID: 26796979)
21. Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
Cheah CY; Dickinson M; Hofman MS; George A; Ritchie DS; Prince HM; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert KE; Carney DA; Tam C; Seymour JF
Ann Hematol; 2014 Jul; 93(7):1193-200. PubMed ID: 24595733
[TBL] [Abstract][Full Text] [Related]
22. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
Shustov A
Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
[TBL] [Abstract][Full Text] [Related]
23. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
[TBL] [Abstract][Full Text] [Related]
24. Peripheral T cell lymphoma: The Sheffield Lymphoma Group experience (1977-2001).
Musson R; Radstone CR; Horsman JM; Hancock H; Goepel JR; Hancock BW;
Int J Oncol; 2003 Jun; 22(6):1363-8. PubMed ID: 12739006
[TBL] [Abstract][Full Text] [Related]
25. Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.
Hawkes EA; Loh Z; Estacio O; Chong G; Ha FJ; Gilbertson M; Grigg A
Br J Cancer; 2018 Aug; 119(5):546-550. PubMed ID: 30033446
[TBL] [Abstract][Full Text] [Related]
26. How to Sequence Therapies in Peripheral T Cell Lymphoma.
Wudhikarn K; Bennani NN
Curr Treat Options Oncol; 2021 Jul; 22(9):74. PubMed ID: 34213653
[TBL] [Abstract][Full Text] [Related]
27. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
Hiniker SM; Pollom EL; Khodadoust MS; Kozak MM; Xu G; Quon A; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):99-106. PubMed ID: 25863757
[TBL] [Abstract][Full Text] [Related]
28. Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial.
Park BB; Kim WS; Suh C; Shin DY; Kim JA; Kim HG; Lee WS
Ann Hematol; 2015 Nov; 94(11):1845-51. PubMed ID: 26251158
[TBL] [Abstract][Full Text] [Related]
29. Contemporary strategies to improve outcomes for peripheral T-cell lymphoma patients following the failure of first-line therapy.
Kallam A; Armitage JO
Expert Rev Hematol; 2020 Jul; 13(7):745-753. PubMed ID: 32478625
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
31. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E;
Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990
[TBL] [Abstract][Full Text] [Related]
32. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project.
Bellei M; Foss FM; Shustov AR; Horwitz SM; Marcheselli L; Kim WS; Cabrera ME; Dlouhy I; Nagler A; Advani RH; Pesce EA; Ko YH; Martinez V; Montoto S; Chiattone C; Moskowitz A; Spina M; Biasoli I; Manni M; Federico M;
Haematologica; 2018 Jul; 103(7):1191-1197. PubMed ID: 29599200
[TBL] [Abstract][Full Text] [Related]
33. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
[TBL] [Abstract][Full Text] [Related]
34. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
[TBL] [Abstract][Full Text] [Related]
35. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
[TBL] [Abstract][Full Text] [Related]
37. Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.
Kewalramani T; Zelenetz AD; Teruya-Feldstein J; Hamlin P; Yahalom J; Horwitz S; Nimer SD; Moskowitz CH
Br J Haematol; 2006 Jul; 134(2):202-7. PubMed ID: 16759221
[TBL] [Abstract][Full Text] [Related]
38. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia.
Lee YP; Yoon SE; Song Y; Kim SJ; Yoon DH; Chen TY; Koh YI; Kang KW; Lee HS; Wei KTK; Lim ST; Poon M; Irawan C; Zhao W; Do YR; Lee MH; Ng SC; Lee WS; Guo Y; Zhang H; Kang HJ; Yun HJ; Kim HJ; Lung DTC; Kwak JY; Han JJ; Mun YC; Oh SY; Shim H; Kwon JH; Sohn BS; Park SK; Jo JC; Ko YH; Jun Z; Kim WS
Int J Hematol; 2021 Sep; 114(3):355-362. PubMed ID: 34302593
[TBL] [Abstract][Full Text] [Related]
40. Peripheral T-cell lymphoma--not otherwise specified.
Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
